Acute Investment Advisory’s Vanguard Short-Term Corporate Bond ETF VCSH Stock Holding History

Acute Investment Advisory’s Portfolio VCSH Stock Details VCSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-106,052	Closed	-$8.02M	–	17
2023 Q2	$8.02M	Buy	106,052 +8,975	+9%	+$682K	4.82%	7
2023 Q1	$7.4M	Sell	97,077 -113,791	-54%	-$8.62M	4.85%	6
2022 Q4	$15.9M	Sell	210,868 -76,034	-27%	-$5.68M	10.81%	3
2022 Q3	$21.3M	Buy	286,902 +41,222	+17%	+$3.14M	15.3%	1
2022 Q2	$18.7M	Buy	245,680 +64,902	+36%	+$4.99M	14.56%	1
2022 Q1	$14.1M	Buy	180,778 +161,539	+840%	+$12.8M	10.54%	3
2021 Q4	$1.56M	Buy	+19,239	New	+$1.57M	1.14%	26

Other funds holding VCSH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

JSTA

Japan Science & Technology Agency Tokyo, Japan $5.29B AUM 8.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Acute Investment Advisory's VCSH Position: Q3 2023 in Review

Acute Investment Advisory sold out of Vanguard Short-Term Corporate Bond ETF (VCSH) in Q3 2023, closing a stake of 106,052 shares — an estimated $8.02M sold.

Acute Investment Advisory first reported a position in VCSH in Q4 2021 and held it in 7 quarters. The position peaked at $21.3M in Q3 2022. 1,215 funds tracked by Wall St. Rank hold VCSH as of Q3 2023.

Acute Investment Advisory reported no remaining Vanguard Short-Term Corporate Bond ETF position as of Q3 2023 after selling out during the quarter.
Acute Investment Advisory sold 106,052 Vanguard Short-Term Corporate Bond ETF shares in Q3 2023, an estimated $8.02M.
Acute Investment Advisory first reported a position in Vanguard Short-Term Corporate Bond ETF in Q4 2021 and held it in 7 quarters.
Acute Investment Advisory's Vanguard Short-Term Corporate Bond ETF position peaked at $21.3M in Q3 2022.
1,215 funds tracked by Wall St. Rank held Vanguard Short-Term Corporate Bond ETF as of Q3 2023.

Based on Acute Investment Advisory's 13F filing for Q3 2023, filed 24 Oct 2023.